CDKN2B-AS1 and ischemic stroke: A clinical trial investigated the relationship between antisense noncoding RNA in the INK4 locus (ANRIL) and high-sensitivity C-reactive protein (hs-CRP) and matrix metalloproteinase-9 (MMP-9) in blood serum of ischemic stroke patients.